About us

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

ABOUT ARENSIA

ARENSIA Exploratory Medicine is a German company with head offices in Düsseldorf specialized in performing sophisticated early phase clinical trials - Phase I / II / PROOF OF CONCEPT, exclusively in patients, in own purpose designed research clinics with full Phase I infrastructure. The study protocols conducted in ARENSIA´s clinics imply testing innovative compounds that require intensive PK/PD assessments and complex investigations associated with hospitalization and/or ambulatory visits.

ARENSIA's research clinics are located across prestigious University and Private Hospitals in Europe, namely in Romania, Bulgaria, Republic of Moldova, Georgia, and Ukraine.

ARENSIA is committed to enabling patients the access to new therapies as early as possible. Patient´s safety and comfort are of paramount importance at all ARENSIA´s clinics.

Involving ARENSIA in early drug development programs leads to a greatly increased efficiency through the reduction in the recruitment periods, and the overall number of sites and countries required. For our Partners/Sponsors, this translates into considerable time and cost savings for the entire project lifecycle while they can progress their innovative compounds much faster to later phases of research.

ARENSIA is trusted by World’s Leading Pharmaceutical and Biotechnology organizations.

VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse